REQUEST A DEMO
Total
USD $0.00
Search more companies

Superior Pharma LTD (Съпириър Фарма ООД) (Bulgaria)

Main Activities: Pharmacies and Drug Stores | Electronic Shopping and Mail-Order Houses
Full name: Superior Pharma LTD Profile Updated: September 04, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Superior Pharma LTD (Съпириър Фарма ООД) is based in Bulgaria, with the head office in Blagoevgrad. It operates in the Pharmacies and Drug Stores sector. The company was established on September 14, 2026. Superior Pharma LTD (Съпириър Фарма ООД) currently employs 7 (2024) people. There was a total growth of 1382.05% in Superior Pharma LTD (Съпириър Фарма ООД)’s total assets over the same period.

Headquarters
Ul. Georgi Andreychin 6
Blagoevgrad; Blagoevgrad; Postal Code: 2700

Contact Details: Purchase the Superior Pharma LTD (Съпириър Фарма ООД) report to view the information.

Basic Information
Total Employees:
Purchase the Superior Pharma LTD (Съпириър Фарма ООД) report to view the information.
Registered Capital:
Purchase the Superior Pharma LTD (Съпириър Фарма ООД) report to view the information.
Financial Auditors:
Purchase the Superior Pharma LTD (Съпириър Фарма ООД) report to view the information.
Incorporation Date:
September 14, 2026
Key Executives
Purchase this report to view the information.
Manager
Company Performance
Financial values in the chart are available after Superior Pharma LTD (Съпириър Фарма ООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Operating Profit
-2566.66%
Net Profit/Loss for the Period
-2566.66%
Total Assets
1382.05%
Total Equity
-2666.66%
Return on Equity (ROE)
-3.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?